TY - JOUR
T1 - Defining a temporal order of genetic requirements for development of mycobacterial biofilms
AU - Yang, Yong
AU - Thomas, Joseph
AU - Li, Yunlong
AU - Vilchèze, Catherine
AU - Derbyshire, Keith M.
AU - Jacobs, William R.
AU - Ojha, Anil K.
N1 - Funding Information:
The authors acknowledge technical help from Kathleen Kulka, Mohammad Islam, Timothy Connors, Jacob Richards and Natalie Boucher, and gifts of phT7MycoMar, pJV62 and pJV53-SacB from Eric Rubin, Graham Hatfull and Todd Gray respectively. Authors acknowledge two Wadsworth Center Core facilities – Applied Genomic Technologies, and Media and Tissue Culture – for their support, as well as Dr. Kimberly Mclive Reed of Health Research Inc. for reading and editing the manuscript. This work was supported by grants from NIH to AKO (AI107595 and AI132422), WRJ (AI26170) and KMD (AI107258). Y.Y., J.T., K.M.D., W.R.J. and A.O. designed experiments. Y.Y., J.T., Y.L. and C.V. performed experiments. Y.Y., K.M.D., W.R.J., and A. O. analyzed data. Y.Y., K.M.D. and A.O. wrote the manuscript.
Publisher Copyright:
© 2017 John Wiley & Sons Ltd
PY - 2017/9
Y1 - 2017/9
N2 - Most mycobacterial species spontaneously form biofilms, inducing unique growth physiologies and reducing drug sensitivity. Biofilm growth progresses through three genetically programmed stages: substratum attachment, intercellular aggregation and architecture maturation. Growth of Mycobacterium smegmatis biofilms requires multiple factors including a chaperonin (GroEL1) and a nucleoid-associated protein (Lsr2), although how their activities are linked remains unclear. Here it is shown that Lsr2 participates in intercellular aggregation, but substratum attachment of Lsr2 mutants is unaffected, thereby genetically distinguishing these developmental stages. Further, a suppressor mutation in a glycopeptidolipid synthesis gene (mps) that results in hyperaggregation of cells and fully restores the form and functions of Δlsr2 mutant biofilms was identified. Suppression by the mps mutation is specific to Δlsr2; it does not rescue the maturation-deficient biofilms of a ΔgroEL1 mutant, thereby differentiating the process of aggregation from maturation. Gene expression analysis supports a stepwise process of maturation, highlighted by temporally separated, transient inductions of iron and nitrogen import genes. Furthermore, GroEL1 activity is required for induction of nitrogen, but not iron, import genes. Together, the findings begin to define molecular checkpoints during development of mycobacterial biofilms.
AB - Most mycobacterial species spontaneously form biofilms, inducing unique growth physiologies and reducing drug sensitivity. Biofilm growth progresses through three genetically programmed stages: substratum attachment, intercellular aggregation and architecture maturation. Growth of Mycobacterium smegmatis biofilms requires multiple factors including a chaperonin (GroEL1) and a nucleoid-associated protein (Lsr2), although how their activities are linked remains unclear. Here it is shown that Lsr2 participates in intercellular aggregation, but substratum attachment of Lsr2 mutants is unaffected, thereby genetically distinguishing these developmental stages. Further, a suppressor mutation in a glycopeptidolipid synthesis gene (mps) that results in hyperaggregation of cells and fully restores the form and functions of Δlsr2 mutant biofilms was identified. Suppression by the mps mutation is specific to Δlsr2; it does not rescue the maturation-deficient biofilms of a ΔgroEL1 mutant, thereby differentiating the process of aggregation from maturation. Gene expression analysis supports a stepwise process of maturation, highlighted by temporally separated, transient inductions of iron and nitrogen import genes. Furthermore, GroEL1 activity is required for induction of nitrogen, but not iron, import genes. Together, the findings begin to define molecular checkpoints during development of mycobacterial biofilms.
UR - http://www.scopus.com/inward/record.url?scp=85021949275&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85021949275&partnerID=8YFLogxK
U2 - 10.1111/mmi.13734
DO - 10.1111/mmi.13734
M3 - Article
C2 - 28628249
AN - SCOPUS:85021949275
SN - 0950-382X
VL - 105
SP - 794
EP - 809
JO - Molecular Microbiology
JF - Molecular Microbiology
IS - 5
ER -